RESUMEN
The article provides an analysis of the possibility of neurotrophic therapy of delayed speech development (DSD) in 266 children who underwent dynamic clinical, laboratory, functional and neuropsychological examinations and received neurotrophic therapy. This study confirmed the effectiveness of neurotrophic therapy in the treatment of as isolated speech disorder (ISD) as well speech disorder in the structure of the general psychomotor developmental delay (PDD). The lack of effect in the use of neuroprotective therapy in every sixth child of the latter group can be a marker for the individualization of the treatment of each individual with an emphasis on non-drug rehabilitation methods. The use of cortexin in monotherapy in the treatment of delayed speech development is justified not only by its effectiveness in improving speech development and good tolerance, but also in connection with an improvement in behavior in children of the studied groups, which is possibly associated with a positive effect on mental activity in general, and on self-control function in particular.
